Immunitybio Stock Market Value
| IBRX Stock | USD 3.00 0.03 0.99% |
| Symbol | Immunitybio |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunitybio. If investors know Immunitybio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunitybio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immunitybio is measured differently than its book value, which is the value of Immunitybio that is recorded on the company's balance sheet. Investors also form their own opinion of Immunitybio's value that differs from its market value or its book value, called intrinsic value, which is Immunitybio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunitybio's market value can be influenced by many factors that don't directly affect Immunitybio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunitybio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunitybio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunitybio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Immunitybio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immunitybio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immunitybio.
| 01/27/2025 |
| 02/26/2025 |
If you would invest 0.00 in Immunitybio on January 27, 2025 and sell it all today you would earn a total of 0.00 from holding Immunitybio or generate 0.0% return on investment in Immunitybio over 30 days. Immunitybio is related to or competes with BioLineRx, Ardelyx, Lexicon Pharmaceuticals, Seres Therapeutics, Protalix Biotherapeutics, PDS Biotechnology, and Elevation Oncology. ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that complement,... More
Immunitybio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immunitybio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immunitybio upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 40.65 | |||
| Value At Risk | (7.52) | |||
| Potential Upside | 9.81 |
Immunitybio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immunitybio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immunitybio's standard deviation. In reality, there are many statistical measures that can use Immunitybio historical prices to predict the future Immunitybio's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | (0.35) |
Immunitybio Backtested Returns
Immunitybio holds Efficiency (Sharpe) Ratio of -0.0777, which attests that the entity had a -0.0777 % return per unit of risk over the last 3 months. Immunitybio exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immunitybio's Standard Deviation of 7.55, market risk adjusted performance of (0.34), and Risk Adjusted Performance of (0.05) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.71, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Immunitybio will likely underperform. At this point, Immunitybio has a negative expected return of -0.59%. Please make sure to check out Immunitybio's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Immunitybio performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.11 |
Insignificant reverse predictability
Immunitybio has insignificant reverse predictability. Overlapping area represents the amount of predictability between Immunitybio time series from 27th of January 2025 to 11th of February 2025 and 11th of February 2025 to 26th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immunitybio price movement. The serial correlation of -0.11 indicates that less than 11.0% of current Immunitybio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.11 | |
| Spearman Rank Test | -0.33 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Immunitybio lagged returns against current returns
Autocorrelation, which is Immunitybio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Immunitybio's stock expected returns. We can calculate the autocorrelation of Immunitybio returns to help us make a trade decision. For example, suppose you find that Immunitybio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Immunitybio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Immunitybio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Immunitybio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Immunitybio stock over time.
Current vs Lagged Prices |
| Timeline |
Immunitybio Lagged Returns
When evaluating Immunitybio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Immunitybio stock have on its future price. Immunitybio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Immunitybio autocorrelation shows the relationship between Immunitybio stock current value and its past values and can show if there is a momentum factor associated with investing in Immunitybio.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immunitybio Stock Analysis
When running Immunitybio's price analysis, check to measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.